Key result
This editorial discusses the evaluation of pulmonary blood volume index by cardiac magnetic resonance as a non-invasive biomarker of haemodynamic congestion in hypertrophic cardiomyopathy.
This editorial discusses the potential of pulmonary blood volume index assessed by cardiac magnetic resonance as a non-invasive quantitative biomarker for haemodynamic congestion in hypertrophic cardiomyopathy.
This editorial refers to ‘Pulmonary blood volume index as a quantitative biomarker of haemodynamic congestion in hypertrophic cardiomyopathy’, by F. Ricci et al., pp. 1368--1376. Since haemodynamic congestion usually precedes clinical symptoms and represents a major parameter impacting the treatment and prognosis of patients with different kind of heart diseases, its assessment has become one of the new spotlights of modern cardiology. Currently, several methods are used for the evaluation of the filling state, each with its strengths and drawbacks. To date, the gold standard for evaluating pulmonary congestion is right heart catheterization (RHC), but its invasive nature limits its use in clinical practice. Echocardiography is the...
No takes yet. Share an insight, caveat, or question.
Houard et al. (2019) conducted an editorial in Hypertrophic cardiomyopathy and pulmonary congestion. Pulmonary blood volume index by cardiac magnetic resonance vs. Right heart catheterization (gold standard) was evaluated. This editorial discusses the evaluation of pulmonary blood volume index by cardiac magnetic resonance as a non-invasive biomarker of haemodynamic congestion in hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: